Company Filing History:
Years Active: 2006
Title: Sven Krappmann: Innovator in Nucleic Acid Technology
Introduction
Sven Krappmann is a notable inventor based in Goettingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid molecules. His work focuses on the development of innovative solutions that enhance the production of polypeptides with specific enzymatic activities.
Latest Patents
Sven Krappmann holds a patent for a nucleic acid molecule that encodes a polypeptide with chorismate mutase activity. This invention relates to a nucleic acid molecule that includes derivatives with at least 10% of the chorismate mutase activity. The patent also covers vectors containing these nucleic acid molecules, host cells that incorporate them, and their applications in producing polypeptides. Furthermore, the invention discusses methods for creating auxotrophic yeast strains and the use of these strains in recombinant gene expression.
Career Highlights
Sven Krappmann is associated with Rhein Biotech Gesellschaft für Neue Biotechnologische Prozesse und Produkte mbH. His work at this company has allowed him to explore various biotechnological processes and products that have the potential to impact the industry significantly. His innovative approach and dedication to research have positioned him as a key figure in his field.
Collaborations
Sven has collaborated with esteemed colleagues such as Gerd Gellissen and Gerhard Braus. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in biotechnology.
Conclusion
Sven Krappmann's contributions to nucleic acid technology exemplify the innovative spirit of modern biotechnology. His patent and ongoing work continue to pave the way for advancements in the production of essential polypeptides.